XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows – operating activities:    
Net loss $ (2,212) $ (4,390)
Non-cash items –     
Share-based plans expense 548 528
Treasury shares issued for 401(k) contribution 1,204 928
Depreciation and amortization 1,380 1,477
Investment/asset impairment charges, net 12 78
Customer financing valuation adjustments (4) 39
Gain on dispositions, net (1) (2)
Other charges and credits, net (21) 388
Changes in assets and liabilities –     
Accounts receivable (523) (22)
Unbilled receivables (547) (678)
Advances and progress billings 2,963 204
Inventories (940) (1,164)
Other current assets 707 (860)
Accounts payable 982 590
Accrued liabilities (574) 2,416
Income taxes receivable, payable and deferred 73 1,382
Other long-term liabilities (254) (114)
Pension and other postretirement plans (785) (1,053)
Customer financing, net 472 76
Other 99 232
Net cash provided by operating activities 2,579 55
Cash flows – investing activities:    
Payments to acquire property, plant and equipment (1,096) (896)
Proceeds from disposals of property, plant and equipment 19 19
Acquisitions, net of cash acquired (19)
Contributions to investments (14,485) (2,773)
Proceeds from investments 10,497 10,182
Other (157) (11)
Net cash (used)/provided by investing activities (5,241) 6,521
Cash flows – financing activities:    
New borrowings 55 19
Debt repayments (5,181) (1,038)
Stock options exercised 45 39
Employee taxes on certain share-based payment arrangements (52) (36)
Other 2
Net cash used by financing activities (5,131) (1,016)
Effect of exchange rate changes on cash and cash equivalents (22) (134)
Net (decrease)/increase in cash & cash equivalents, including restricted (7,815) 5,426
Cash & cash equivalents, including restricted, at beginning of year 14,647 8,104
Cash & cash equivalents, including restricted, at end of period 6,832 13,530
Less restricted cash & cash equivalents, included in Investments 21 36
Cash and cash equivalents at end of period $ 6,811 $ 13,494